ABL Bio Inc Cash Flow Reinvestment Rate
ABL Bio Inc cash flow reinvestment rate. ABL Bio Inc (298380) has a Cash Flow Reinvestment Rate of 0.04x as of March 2026, reinvesting ₩1.29 Billion (capex ₩243.74 Million plus investments ₩1.04 Billion) from operating cash flow of ₩32.84 Billion. Explore 298380 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ABL Bio Inc (2022–2022)
Cash flow reinvestment rate of ABL Bio Inc from 2022 to 2022. Historical reinvestment intensity for ABL Bio Inc across 1 annual periods. Explore 298380 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
ABL Bio Inc Cash Flow Reinvestment Rate by Year (2022–2022)
ABL Bio Inc cash flow reinvestment rate by year from 2022 to 2022. Year-by-year capital reinvestment analysis for ABL Bio Inc. For the full cash flow conversion analysis, see ABL Bio Inc cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.67x | ₩48.29 Billion | ₩72.13 Billion | ₩2.06 Billion | — |